Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. (Lancet, 2020)

(untitled) - Wang, Y; Zhang, D; Du, G; Du, R; Zhao, J; Jin, Y; Fu, S; Gao, L; Cheng, Z; Lu, Q; Hu, Y; Luo, G; et al.